Cases
Zeltiq Aesthetics, Inc. (NASDAQ: ZLTQ)
Merger
Overview
Overview
- Date:
- 3/23/2017
- Company Name:
- Zeltiq Aesthetics, Inc.
- Stock Symbol:
- ZLTQ
- Company Name - Buyer:
- Allergan plc
- Stock Symbol - Buyer:
- AGN
- Class Period:
- FROM 3/13/2017
- Status:
- Closed/Complete
- Merger Announcement Date:
- 2/13/2017
- Court:
- U.S. District Court: Northern California
NEW YORK, March 23, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who held Zeltiq Aesthetics, Inc. (NASDAQ: ZLTQ) securities on March 13, 2017 (the “Class Period”).
On February 13, 2017, the two parties announced the signing of a definitive merger agreement pursuant to which Allergan plc will acquire Zeltiq in a deal worth $2.475 billion. As a result of the merger, Zeltiq shareholders are only anticipated to receive $56.50 in cash for each share of Zeltiq common stock.
The Complaint alleges that the Company failed to conduct a fair sales process and failed to disclose all material information regarding the sale of the Company.
If you held Zeltiq securities during the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On February 13, 2017, the two parties announced the signing of a definitive merger agreement pursuant to which Allergan plc will acquire Zeltiq in a deal worth $2.475 billion. As a result of the merger, Zeltiq shareholders are only anticipated to receive $56.50 in cash for each share of Zeltiq common stock.
The Complaint alleges that the Company failed to conduct a fair sales process and failed to disclose all material information regarding the sale of the Company.
If you held Zeltiq securities during the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.